These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25134439)
1. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products. Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439 [TBL] [Abstract][Full Text] [Related]
2. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327 [TBL] [Abstract][Full Text] [Related]
3. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products. Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model. Pohler P; Lehmann J; Veneruso V; Tomm J; von Bergen M; Lambrecht B; Kohn B; Weingart C; Müller TH; Seltsam A Transfusion; 2012 Nov; 52(11):2414-26. PubMed ID: 22404822 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update. Seghatchian J; Tolksdorf F Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Fast LD; DiLeone G; Marschner S Transfusion; 2011 Jul; 51(7):1397-404. PubMed ID: 21155832 [TBL] [Abstract][Full Text] [Related]
7. White blood cell inactivation after treatment with riboflavin and ultraviolet light. Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002 [TBL] [Abstract][Full Text] [Related]
8. Developments in the prevention of transfusion-associated graft-versus-host disease. Fast LD Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439 [TBL] [Abstract][Full Text] [Related]
9. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method. Sandgren P; Tolksdorf F; Struff WG; Gulliksson H Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668 [TBL] [Abstract][Full Text] [Related]
10. Transfusion of pathogen-reduced platelet components without leukoreduction. Sim J; Tsoi WC; Lee CK; Leung R; Lam CCK; Koontz C; Liu AY; Huang N; Benjamin RJ; Vermeij HJ; Stassinopoulos A; Corash L; Lie AKW Transfusion; 2019 Jun; 59(6):1953-1961. PubMed ID: 30919465 [TBL] [Abstract][Full Text] [Related]
11. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review. Cid J Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219 [TBL] [Abstract][Full Text] [Related]
12. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets. Bashir S; Cookson P; Wiltshire M; Hawkins L; Sonoda L; Thomas S; Seltsam A; Tolksdorf F; Williamson LM; Cardigan R Transfusion; 2013 May; 53(5):990-1000. PubMed ID: 22905813 [TBL] [Abstract][Full Text] [Related]
13. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components. Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light. Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163 [TBL] [Abstract][Full Text] [Related]
15. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Mohr H; Steil L; Gravemann U; Thiele T; Hammer E; Greinacher A; Müller TH; Völker U Transfusion; 2009 Dec; 49(12):2612-24. PubMed ID: 19682340 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets. Castro E; González LM; Rubio JM; Ramiro R; Gironés N; Montero E Transfusion; 2014 Sep; 54(9):2207-16. PubMed ID: 24666393 [TBL] [Abstract][Full Text] [Related]
17. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets. Tynngård N; Trinks M; Berlin G Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519 [TBL] [Abstract][Full Text] [Related]
18. Treatment of platelet concentrates with ultraviolet C light for pathogen reduction increases cytokine accumulation. Sandgren P; Berlin G; Tynngård N Transfusion; 2016 Jun; 56(6):1377-83. PubMed ID: 27080102 [TBL] [Abstract][Full Text] [Related]
19. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583 [TBL] [Abstract][Full Text] [Related]